Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gotoh, M.
Right arrow Articles by Koyama, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotoh, M.
Right arrow Articles by Koyama, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 4 713-717, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease

M Gotoh, S Nagase, K Aoyagi, A Hirayama, K Takemura, A Ueda, C Tomida, H Kikuchi and A Koyama
Department of Internal Medicine, University of Tsukuba, Ibaraki, Japan.

BACKGROUND: Patients with end-stage renal disease are thought to be in a highly peroxidative state, based on studies showing decreased serum antioxidant activity and increased peroxidative products. In this study we confirm these findings by examining lipid peroxidation in subcutaneous fat tissue in uraemia. SUBJECTS AND METHODS: Twenty-seven subcutaneous fat samples were taken from patients with end-stage renal disease when they underwent intervention for arteriovenous fistula for haemodialyis or for catheter insertion for continuous ambulatory peritoneal dialysis. The control samples were taken from 11 patients with normal renal function and without any history of renal disease who had surgical interventions. Lipid peroxides were measured as thiobarbituric acid reactive substance. RESULTS: The concentration of thiobarbituric acid reactive substances in subcutaneous fat tissue in the patients with end-stage renal disease is 1.223 +/- 0.636 nmol/mg fat tissue (mean +/- SD) whereas the level in the control group is 0.097 +/- 0.054 nmol/mg fat tissue. A comparison of the two groups by Student's t test revealed a highly significant difference (P < 0.001). CONCLUSIONS: This study supports the finding of a severe peroxidative state in patients with end-stage renal disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Barazzoni, A. Bernardi, F. Biasia, A. Semolic, A. Bosutti, M. Mucci, F. Dore, M. Zanetti, and G. Guarnieri
Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease--impact on plasma adiponectin concentration
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R47 - R54.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Nagase, A. Hirayama, A. Ueda, T. Oteki, K. Takada, M. Inoue, Y. Shimozawa, J. Terao, and A. Koyama
Light-Shielded Hemodialysis Prevents Hypotension and Lipid Peroxidation by Inhibiting Nitric Oxide Production
Clin. Chem., December 1, 2005; 51(12): 2397 - 2398.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Nakayama, S. Akiyama, M. Inagaki, Y. Gotoh, and K. Oguchi
Dehydroascorbic acid and oxidative stress in haemodialysis patients
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 574 - 579.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.